======= UIMC1 =======
== Gene Information ==
* **Official Symbol**: UIMC1
* **Official Name**: ubiquitin interaction motif containing 1
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=51720|51720]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q96RL1|Q96RL1]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=UIMC1&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20UIMC1|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/609433|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: N/A
No Pfam Domain information is available for this gene.
|histone H2A K63-linked deubiquitination|
|BRCA1-A complex|
|signal transduction involved in G2 DNA damage checkpoint|
|histone deubiquitination|
|K63-linked polyubiquitin modification-dependent protein binding|
|G2 DNA damage checkpoint|
|protein K63-linked deubiquitination|
|double-strand break repair via nonhomologous end joining|
|non-recombinational repair|
|positive regulation of DNA repair|
|signal transduction involved in DNA damage checkpoint|
|signal transduction involved in DNA integrity checkpoint|
|signal transduction involved in cell cycle checkpoint|
|positive regulation of response to DNA damage stimulus|
|negative regulation of cell cycle G2/M phase transition|
|signal transduction in response to DNA damage|
|regulation of DNA repair|
|histone binding|
|DNA damage checkpoint|
|DNA integrity checkpoint|
|response to ionizing radiation|
|double-strand break repair|
|cell cycle checkpoint|
|positive regulation of DNA metabolic process|
|regulation of cell cycle G2/M phase transition|
|regulation of response to DNA damage stimulus|
|negative regulation of cell cycle phase transition|
|protein deubiquitination|
|nuclear body|
|protein modification by small protein removal|
|negative regulation of cell cycle process|
|regulation of DNA metabolic process|
|histone modification|
|covalent chromatin modification|
|response to radiation|
|regulation of cell cycle phase transition|
|DNA repair|
|negative regulation of cell cycle|
|chromatin organization|
|regulation of cellular response to stress|
|DNA metabolic process|
|regulation of cell cycle process|
|cellular response to DNA damage stimulus|
|protein modification by small protein conjugation or removal|
|chromosome organization|
|response to abiotic stimulus|
|regulation of cell cycle|
|negative regulation of transcription, DNA-templated|
|negative regulation of nucleic acid-templated transcription|
|negative regulation of RNA biosynthetic process|
|proteolysis|
|negative regulation of RNA metabolic process|
|negative regulation of cellular macromolecule biosynthetic process|
|negative regulation of nucleobase-containing compound metabolic process|
|negative regulation of macromolecule biosynthetic process|
|regulation of response to stress|
|negative regulation of cellular biosynthetic process|
|negative regulation of biosynthetic process|
|intracellular signal transduction|
|cellular response to stress|
|negative regulation of gene expression|
|positive regulation of nucleobase-containing compound metabolic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp270|Campthothecin 0.001μM R06 exp270]]|-2.35|
|[[:results:exp198|Etoposide 0.1μM R05 exp198]]|-2.22|
|[[:results:exp33|Rotenone 2μM R00 exp33]]|-2.21|
|[[:results:exp36|TRAIL 50ng/ml R00 exp36]]|-2.06|
|[[:results:exp264|Arsenate 40μM R06 exp264]]|-2.05|
|[[:results:exp10|CCCP 0.1μM R00 exp10]]|-2.01|
|[[:results:exp507|Monensin 0.3μM R08 exp507]]|-2|
|[[:results:exp299|Talazoparib 0.006μM R06 exp299]]|-1.95|
|[[:results:exp5|Alpha-Amanitin 0.5μM R00 exp5]]|-1.88|
|[[:results:exp316|Geldanamycin 0.015 to 0.025μM on day4 R07 exp316]]|-1.88|
|[[:results:exp444|THZ531 0.225μM R08 exp444]]|-1.75|
|[[:results:exp169|BH1 1μM R04 exp169]]|-1.74|
|[[:results:exp21|MLN-4924 0.2μM R00 exp21]]|-1.74|
|[[:results:exp228|Demecolcine 0.03μM R05 exp228]]|-1.73|
|[[:results:exp389|PF-06409577 20μM R07 exp389]]|1.74|
|[[:results:exp142|OICR-9429 10μM R03 exp142]]|1.8|
|[[:results:exp145|PNU96415E 10μM R03 exp145]]|2.15|
^Gene^Correlation^
|[[:human genes:r:rrm1|RRM1]]|0.476|
Global Fraction of Cell Lines Where Essential: 0/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/25|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/15|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/14|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 5188
* **Expression level (log2 read counts)**: 6.43
{{:chemogenomics:nalm6 dist.png?nolink |}}